Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-03

Clinical Trial Update: Cardioprotection on Chemotherapy-Induced Cardiotoxicity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a cardioprotective strategy to prevent chemotherapy-induced cardiotoxicity is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ain Shams University | Conditions: Cardiotoxicity | Phase 3 | Status: RECRUITING